Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Brugada syndrome.

P Brugada1, R Brugada, J Brugada

  • 1Cardiovascular Center, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium. Pedro.Brugada@pi.be

Current Cardiology Reports
|November 3, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IMPACT OF RADIOFREQUENCY CATHETER ABLATION ON HEALTH-RELATED QUALITY OF LIFE ASSESSED BY THE SF-36 QUESTIONNAIRE IN PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA.

Georgian medical news·2018
Same author

INFLUENCE OF CATHETER ABLATION OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA ON PATIENTS' ANXIETY.

Georgian medical news·2018
Same author

Clinical News.

British journal of hospital medicine (London, England : 2005)·2018
Same author

[Hypothermia-induced ECG changes: characteristic, but not specific].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2017
Same author

ANXIETY LEVELS IN PATIENTS WITH PAROXY-SMAL SUPRAVENTRICULAR TACHYCARDIA IN RELATION WITH THE PATIENT DEMOGRAPHICS, TYPE OF SUPRAVENTRICULAR TACHYCARDIA AND THEIR PERSONALITY TYPE.

Georgian medical news·2017
Same author

Only a boost away from re-entry.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2017
Same journal

Endovascular Therapy for Acute Ischemic Stroke: Current Evidence and Evolving Practices.

Current cardiology reports·2026
Same journal

Diagnostic Tests for Stage B Heart Failure.

Current cardiology reports·2026
Same journal

Cardioimmunology of Myocarditis: Targeting the IL-1 Pathway.

Current cardiology reports·2026
Same journal

Antithrombotic Management in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.

Current cardiology reports·2026
Same journal

Transcriptome Reprogramming in Heart Failure: The Hidden Splicing Code.

Current cardiology reports·2026
Same journal

Diagnosis and Management of Loeys-Dietz Syndrome: Evidence Gaps and Future Directions.

Current cardiology reports·2026
See all related articles

Brugada syndrome is an inherited heart condition causing sudden death, often due to SCN5A gene mutations. Early recognition of its unique ECG patterns and prompt defibrillator implantation are crucial for preventing mortality.

Area of Science:

  • Cardiology
  • Genetics
  • Electrophysiology

Background:

  • Brugada syndrome is a hereditary cardiac disease.
  • It leads to sudden cardiac death in individuals with structurally normal hearts.
  • Mutations in the SCN5A gene are the primary cause.

Purpose of the Study:

  • To highlight the diagnostic electrocardiogram (ECG) features of Brugada syndrome.
  • To emphasize the importance of recognizing ECG variants and concealed forms.
  • To discuss the high mortality and effective treatment strategies.

Main Methods:

  • Review of characteristic electrocardiogram findings in Brugada syndrome.
  • Discussion of diagnostic challenges, including concealed forms.
  • Analysis of treatment outcomes and mortality rates.

Related Experiment Videos

Main Results:

  • Brugada syndrome presents with a distinct ST segment elevation in ECG leads V1-V3.
  • Concealed forms require provocation with Class I antiarrhythmic drugs for diagnosis.
  • Untreated patients face a significant annual mortality risk of approximately 10%.

Conclusions:

  • Early recognition of Brugada syndrome's ECG patterns is vital for all physicians.
  • Implantable defibrillators are the only proven effective treatment to prevent sudden death.
  • Genetic testing for SCN5A mutations aids in diagnosis and family screening.